Compare Sterling Biotech with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs ALKEM LABORATORIES - Comparison Results

STERLING BIOTECH     Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH ALKEM LABORATORIES STERLING BIOTECH/
ALKEM LABORATORIES
 
P/E (TTM) x -0.4 - - View Chart
P/BV x 0.0 6.6 0.2% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 STERLING BIOTECH   ALKEM LABORATORIES
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
ALKEM LABORATORIES
Mar-16
STERLING BIOTECH/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs111,589 0.7%   
Low Rs31,232 0.3%   
Sales per share (Unadj.) Rs26.8417.5 6.4%  
Earnings per share (Unadj.) Rs-15.056.3 -26.6%  
Cash flow per share (Unadj.) Rs-5.564.7 -8.4%  
Dividends per share (Unadj.) Rs012.70 0.0%  
Dividend yield (eoy) %00.9 0.0%  
Book value per share (Unadj.) Rs54.9292.9 18.7%  
Shares outstanding (eoy) m267.87119.57 224.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.33.4 7.7%   
Avg P/E ratio x-0.525.1 -1.9%  
P/CF ratio (eoy) x-1.321.8 -5.8%  
Price / Book Value ratio x0.14.8 2.6%  
Dividend payout %022.6 0.0%   
Avg Mkt Cap Rs m1,862168,653 1.1%   
No. of employees `0001.4NA-   
Total wages/salary Rs m5479,171 6.0%   
Avg. sales/employee Rs Th5,303.3NM-  
Avg. wages/employee Rs Th403.8NM-  
Avg. net profit/employee Rs Th-2,959.0NM-  
INCOME DATA
Net Sales Rs m7,18149,915 14.4%  
Other income Rs m431,645 2.6%   
Total revenues Rs m7,22351,561 14.0%   
Gross profit Rs m9478,482 11.2%  
Depreciation Rs m2,5431,006 252.9%   
Interest Rs m4,377671 652.7%   
Profit before tax Rs m-5,9318,451 -70.2%   
Minority Interest Rs m0-114 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,9241,606 -119.8%   
Profit after tax Rs m-4,0076,731 -59.5%  
Gross profit margin %13.217.0 77.6%  
Effective tax rate %32.419.0 170.7%   
Net profit margin %-55.813.5 -413.8%  
BALANCE SHEET DATA
Current assets Rs m14,33527,062 53.0%   
Current liabilities Rs m49,80915,324 325.1%   
Net working cap to sales %-494.023.5 -2,100.8%  
Current ratio x0.31.8 16.3%  
Inventory Days Days40367 606.5%  
Debtors Days Days17141 413.4%  
Net fixed assets Rs m55,43212,610 439.6%   
Share capital Rs m268239 112.0%   
"Free" reserves Rs m13,93534,490 40.4%   
Net worth Rs m14,70135,027 42.0%   
Long term debt Rs m9,4781,212 782.3%   
Total assets Rs m73,98854,387 136.0%  
Interest coverage x-0.413.6 -2.6%   
Debt to equity ratio x0.60 1,863.8%  
Sales to assets ratio x0.10.9 10.6%   
Return on assets %0.513.6 3.7%  
Return on equity %-27.319.2 -141.8%  
Return on capital %-6.424.9 -25.9%  
Exports to sales %25.912.9 200.1%   
Imports to sales %0.23.1 5.5%   
Exports (fob) Rs m1,8606,461 28.8%   
Imports (cif) Rs m121,540 0.8%   
Fx inflow Rs m1,8606,563 28.3%   
Fx outflow Rs m253,012 0.8%   
Net fx Rs m1,8353,552 51.7%   
CASH FLOW
From Operations Rs m1,7197,259 23.7%  
From Investments Rs m-3,1481,864 -168.9%  
From Financial Activity Rs m1,426-9,273 -15.4%  
Net Cashflow Rs m-3-150 2.3%  

Share Holding

Indian Promoters % 33.9 66.9 50.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 33.1 -  
FIIs % 9.9 0.0 -  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 0.0 -  
Shareholders   21,482 68,381 31.4%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   ALEMBIC LTD  SUN PHARMA  PFIZER  FDC LTD.  AUROBINDO PHARMA  

Compare STERLING BIOTECH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Jumps 1,921 Points, FM's Tax Relief, and Top Cues in Focus Today(Pre-Open)

Share markets in India jumped sharply on Friday after Finance Minister Nirmala Sitharaman announced a slew of measures in her media briefing ahead of the GST Council meet.

Related Views on News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

My 7 Stocks to Buy Are Companies Which Will Be a Big Part of New India(The 5 Minute Wrapup)

Sep 19, 2019

The India we knew is changing. Here's how you can benefit from this change.

Did the Tax Bonanza Really Deserve a 2,000-point Gain on the Sensex?(Profit Hunter)

Sep 20, 2019

Are investors overdoing their euphoria post the corporate tax cut bonanza?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 8-QTR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS